COVID-19: a vascular nightmare unfolding
The emergence of COVID-19 has been associated with an increased risk of arteriovenous thrombosis, with immune inflammation playing a significant role in the pathogenesis of thrombosis. Numerous drug-related clinical trials have been undertaken to prevent thrombosis, and guidelines for its prevention...
Saved in:
| Main Authors: | Qinan Yin, Youjin Huang, Hulin Wang, Yin Wang, Xuefei Huang, Yujie Song, Yueyuan Wang, Lizhu Han, Bian Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593885/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Addressing challenges in pediatric thrombosis: a comprehensive guideline development
by: Yin Wang, et al.
Published: (2025-01-01) -
Evaluation of Antiplatelet/Anticoagulant Use and Prognosis in Primary Thrombophilia Patients with COVID-19
by: Cenk Sunu, et al.
Published: (2024-12-01) -
Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastography
by: Mengyun Lu, et al.
Published: (2021-07-01) -
Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
by: Abel Tenaw Tasamma, et al.
Published: (2025-01-01) -
MODERN ASPECTS OF COAGULOPATHY DEVELOPMENT IN PATIENTS WITH COVID-19 INFECTION: LITERATURE REVIEW
by: M.O. Dudchenko, et al.
Published: (2021-12-01)